BAAT
Bile acid-CoA:amino acid N-acyltransferase
Also known as: BAAT_HUMAN, BAT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14032
- Gene
- BAAT
- Ensembl
- ENSG00000136881
- Chromosome
- 9
- Canonical length
- 418 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a liver enzyme that catalyzes the transfer of C24 bile acids from the acyl-CoA thioester to either glycine or taurine, the second step in the formation of bile acid-amino acid conjugates. The bile acid conjugates then act as a detergent in the gastrointestinal tract, which enhances lipid and fat-soluble vitamin absorption. Defects in this gene are a cause of familial hypercholanemia (FHCA). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
418 residues, UniProt reviewed canonical sequence.
>Q14032|BAAT
1 MIQLTATPVS ALVDEPVHIR ATGLIPFQMV SFQASLEDEN GDMFYSQAHY RANEFGEVDL
61 NHASSLGGDY MGVHPMGLFW SLKPEKLLTR LLKRDVMNRP FQVQVKLYDL ELIVNNKVAS
121 APKASLTLER WYVAPGVTRI KVREGRLRGA LFLPPGEGLF PGVIDLFGGL GGLLEFRASL
181 LASRGFASLA LAYHNYEDLP RKPEVTDLEY FEEAANFLLR HPKVFGSGVG VVSVCQGVQI
241 GLSMAIYLKQ VTATVLINGT NFPFGIPQVY HGQIHQPLPH SAQLISTNAL GLLELYRTFE
301 TTQVGASQYL FPIEEAQGQF LFIVGEGDKT INSKAHAEQA IGQLKRHGKN NWTLLSYPGA
361 GHLIEPPYSP LCCASTTHDL RLHWGGEVIP HAAAQEHAWK EIQRFLRKHL IPDVTSQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BAAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 675 nTPM
Expression across tissuesHPA
Tissue
- liver: 675 nTPM
- gallbladder: 16 nTPM
- bone marrow: 1.2 nTPM
- skeletal muscle: 1 nTPM
- pancreas: 0.9 nTPM
- cerebral cortex: 0.7 nTPM
Single-cell type
- hepatocytes: 675 nCPM
- cholangiocytes: 49 nCPM
- brain excitatory neurons: 8.9 nCPM
- brain inhibitory neurons: 7.9 nCPM
- other brain neurons: 6.1 nCPM
- myonuclei: 5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 3.5 nTPM
- white matter: 2.9 nTPM
- basal ganglia: 2.4 nTPM
- hippocampal formation: 2.4 nTPM
- cerebellum: 2.3 nTPM
- pons: 2.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BAAT.
Disease | AllUniProt
Conditions BAAT is implicated in, by any mechanism.
- Hypercholanemia, familial 3 (FHCA3) MIM:619232
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 208 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bile acid conjugation defect 1
- BAAT-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acyl-CoA metabolic process
- animal organ regeneration
- bile acid biosynthetic process
- bile acid metabolic process
- fatty acid metabolic process
- glycine metabolic process
- liver development
- taurine metabolic process
- bile acid conjugation
Molecular functions
- acyltransferase activity
- carboxylic ester hydrolase activity
- choloyl-CoA hydrolase activity
- fatty acyl-CoA hydrolase activity
- long-chain fatty acyl-CoA hydrolase activity
- medium-chain fatty acyl-CoA hydrolase activity
- N-acyltransferase activity
- very long-chain fatty acyl-CoA hydrolase activity
- glycine N-choloyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Acyl-CoA thioester hydrolase/bile acid-CoA amino acid N-acetyltransferase
- BAAT/Acyl-CoA thioester hydrolase C-terminal
- Acyl-CoA thioesterase, long chain
- Alpha/Beta hydrolase fold
- Acyl-CoA thioester hydrolase/BAAT, N-terminal
- Acyl-CoA thioester hydrolase/BAAT N-terminal region
- BAAT / Acyl-CoA thioester hydrolase C terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BAAT as an antibody target. Whether an autoantibody or antibody against BAAT could matter depends on whether native BAAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BAAT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BAAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...